New Key Statistics Module, Z-Score and F-Score
NAS:IRWD Key Ratios
Market Cap $ M | 1,363.37 |
Enterprise Value $ M | 1,972.66 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 3.21 |
Price/Free Cash Flow | 7.94 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 442.00 |
EPS (TTM) $ | -6.51 |
Beneish M-Score | -3.92 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -524.10 |
EV-to-EBIT | -2.13 |
EV-to-EBITDA | -2.13 |
PEG | -- |
Shares Outstanding M | 156.53 |
Net Margin (%) | -226.37 |
Operating Margin % | 38.02 |
Pre-tax Margin (%) | -214.14 |
Quick Ratio | 0.84 |
Current Ratio | 0.84 |
ROA % (ttm) | -130.02 |
ROE % (ttm) | -1,456.68 |
ROIC % (ttm) | 38.76 |
Dividend Yield % | -- |
Altman Z-Score | -9.72 |
Piotroski F-Score | 4.00 |
Positive ROA | N |
Positive CFROA | Y |
Higher ROA y-y | N |
Cash flow > Earnings | Y |
Lower Leverage y-y | N |
Higher Current Ratio y-y | N |
Less Shares Outstanding y-y | Y |
Gross Margin Increase y-y | N |
Higher Asset Turnover y-y | Y |
IRWD Number of Guru Trades
IRWD Volume of Guru Trades
Gurus Latest Trades with NAS:IRWD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:IRWD is held by these investors
Total 5
Ironwood Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:IRWD
Total 0- 1